<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327677</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00029336</org_study_id>
    <nct_id>NCT01327677</nct_id>
  </id_info>
  <brief_title>Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring</brief_title>
  <official_title>Post Craniotomy Analgesia Safety Monitoring With ET CO2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to compare two methods of giving fentanyl, a narcotic often given
      to patients following brain surgery and determine if one method has more side effects than
      the other. Both of these methods are available in the postoperative treatment of pain. This
      research also is being done to determine if patients receiving narcotic pain medicine will
      benefit from additional monitoring of carbon dioxide levels. Since narcotic pain medicines
      can slow down breathing, The investigators want to see if measuring exhaled carbon dioxide
      levels will help identify a slower breathing rate and improve safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Depression</measure>
    <time_frame>up to 24 hours postoperatively</time_frame>
    <description>Defined by minimum respiratory rate (breaths/minute).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory Depression</measure>
    <time_frame>Up to 24 hours postoperatively.</time_frame>
    <description>Defined by maximal End Tidal CO2 (mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoxia</measure>
    <time_frame>up to 24 hours postoperatively</time_frame>
    <description>Defined by minimum oxygen saturation (SaO2)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mean Fentanyl Consumption</measure>
    <time_frame>up to 24 hours postoperatively</time_frame>
    <description>Amount of cumulative fentanyl consumed in mcg</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">137</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Pro re nata (PRN) fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A nurse can give the patient up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous Patient-controlled Analgesia (IVPCA) fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl will be given with a Patient Controlled Analgesia (PCA) pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>25-50 mcg every 20 minutes</description>
    <arm_group_label>Pro re nata (PRN) fentanyl</arm_group_label>
    <other_name>Fentanyl PRN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>20mcg/demand dose with an 8 minute lock out</description>
    <arm_group_label>Intravenous Patient-controlled Analgesia (IVPCA) fentanyl</arm_group_label>
    <other_name>Fentanyl PCA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male and female, English speaking patients undergoing supratentorial craniotomy
             for tumor under general anesthesia at the Johns Hopkins Hospital will be eligible for
             this study.

        Exclusion Criteria:

          -  pregnant women

          -  patients with post operative neurological changes

          -  patients who remain intubated post-operatively

          -  patients who require the use of concomitant administration of sedatives

               -  patients who are unable to initiate a PCA bolus

               -  patients who are unable to communicate verbally

               -  patients who are allergic to fentanyl

          -  patients who have a history of narcotic abuse

          -  patients who have a history of chronic pain requiring opioids

          -  patients who have been in any investigational drug trial within 1 month of the
             treatment day

          -  patients who have chronic respiratory insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Athir H Morad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2011</study_first_submitted>
  <study_first_submitted_qc>March 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2011</study_first_posted>
  <results_first_submitted>March 9, 2017</results_first_submitted>
  <results_first_submitted_qc>May 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 31, 2017</results_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain management</keyword>
  <keyword>opioid analgesic therapy</keyword>
  <keyword>safety</keyword>
  <keyword>craniotomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PRN Fentanyl</title>
          <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
        </group>
        <group group_id="P2">
          <title>PCA Fentanyl</title>
          <description>A patient can self-administer fentanyl intravenously using a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PRN Fentanyl</title>
          <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
        </group>
        <group group_id="B2">
          <title>IVPCA Fentanyl</title>
          <description>A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="56"/>
            <count group_id="B3" value="104"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>As the result of patients either not completing the assigned intervention due to premature withdrawal from the protocol, protocol violations, or incomplete data capture, the number of analyzed patients was reduced compared to the originally allocated number.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.1" spread="14.0"/>
                    <measurement group_id="B2" value="50.4" spread="13.7"/>
                    <measurement group_id="B3" value="49.8" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>As the result of patients either not completing the assigned intervention due to premature withdrawal from the protocol, protocol violations, or incomplete data capture, the number of analyzed patients was reduced compared to the originally allocated number.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>As the result of patients either not completing the assigned intervention due to premature withdrawal from the protocol, protocol violations, or incomplete data capture, the number of analyzed patients was reduced compared to the originally allocated number.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Respiratory Depression</title>
        <description>Defined by minimum respiratory rate (breaths/minute).</description>
        <time_frame>up to 24 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRN Fentanyl</title>
            <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>PCA Fentanyl</title>
            <description>A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Depression</title>
          <description>Defined by minimum respiratory rate (breaths/minute).</description>
          <units>breaths/minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="0.4"/>
                    <measurement group_id="O2" value="10.5" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Respiratory Depression</title>
        <description>Defined by maximal End Tidal CO2 (mmHg)</description>
        <time_frame>Up to 24 hours postoperatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>(Pro re Nata) PRN Fentanyl</title>
            <description>A nurse can give the patient up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>Intravenous Patient-controlled Analgesia (IVPCA) Fentanyl</title>
            <description>Fentanyl will be given with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Depression</title>
          <description>Defined by maximal End Tidal CO2 (mmHg)</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.4" spread="0.6"/>
                    <measurement group_id="O2" value="41.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypoxia</title>
        <description>Defined by minimum oxygen saturation (SaO2)</description>
        <time_frame>up to 24 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRN Fentanyl</title>
            <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>PCA Fentanyl</title>
            <description>A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
          </group>
        </group_list>
        <measure>
          <title>Hypoxia</title>
          <description>Defined by minimum oxygen saturation (SaO2)</description>
          <units>Percent Oxygen Saturation</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" spread="0.2"/>
                    <measurement group_id="O2" value="96.3" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Mean Fentanyl Consumption</title>
        <description>Amount of cumulative fentanyl consumed in mcg</description>
        <time_frame>up to 24 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PRN Fentanyl</title>
            <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
          </group>
          <group group_id="O2">
            <title>PCA Fentanyl</title>
            <description>A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Fentanyl Consumption</title>
          <description>Amount of cumulative fentanyl consumed in mcg</description>
          <units>micrograms/ hour</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" spread="2.65"/>
                    <measurement group_id="O2" value="26.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected over the course of patient enrollment in the Neurosciences Critical Care Unit, within 24 hours of surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PRN Fentanyl</title>
          <description>A nurse can administer up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.
Fentanyl: 25-50 mcg every 20 minutes</description>
        </group>
        <group group_id="E2">
          <title>PCA Fentanyl</title>
          <description>A patient can self-administer fentanyl intravenously with a Patient Controlled Analgesia (PCA) pump.
Fentanyl: 20mcg/demand dose with an 8 minute lock out</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Athir Morad, M.D.</name_or_title>
      <organization>Johns Hopkins University School of Medicine</organization>
      <phone>4109552611</phone>
      <email>morada@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

